AEI · Alset Inc.

This sales contraction amplified operating pressures, expanding the operating loss to -$15.2 million, a 268.0% worsening from FY2024's -$4.1 million, resulting in an operating margin of -338.9%. The income statement trajectory culminated in a net loss of -$47.4 million, up 1095.6% from -$4.0 million, with diluted EPS deteriorating to -$2.22 from -$0.43. Item 7 discloses that equity investments like Nervotec were measured under ASC 321 at cost less impairment, adjusted for observable price changes, contributing to the net loss expansion beyond operating levels.

Operationally, Alset has provided global capital and management services to affiliated companies for Asian market access, while investment securities without readily determinable fair values follow cost-minus-impairment accounting. Outlook signals in Item 7 indicate expectations for rental revenue growth through additional house acquisitions and successful leasing, contrasting with the F&B business, which Item 7A flags as incurring ongoing losses with no foreseeable profitability. These dynamics underscore a strategic pivot from cyclical property sales toward recurring rental income, amid investment-related challenges and cash burn that management monitors closely through its real estate holdings.